Related Research Articles
KKR & Co. Inc., also known as Kohlberg Kravis Roberts & Co., is an American global investment company that manages multiple alternative asset classes, including private equity, energy, infrastructure, real estate, credit, and, through its strategic partners, hedge funds. As of December 31, 2021, the firm had completed more than 650 private equity investments in portfolio companies with approximately $675 billion of total enterprise value. As of December 31, 2021, assets under management ("AUM") and fee paying assets under management ("FPAUM") were $471 billion and $357 billion, respectively.
TPG Inc., previously known as Texas Pacific Group and TPG Capital, is an American investment company. The private equity firm is focused on leveraged buyouts and growth capital. TPG manages investment funds in growth capital, venture capital, public equity, and debt investments. The firm invests in a range of industries including consumer/retail, media and telecommunications, industrials, technology, travel, leisure, and health care.
Bain Capital is an American private investment firm based in Boston. It specializes in private equity, venture capital, credit, public equity, impact investing, life sciences, and real estate. Bain Capital invests across a range of industry sectors and geographic regions. As of 2022, the firm managed approximately $160 billion of investor capital. The firm was founded in 1984 by partners from the consulting firm Bain & Company. The company is headquartered at 200 Clarendon Street in Boston with 22 offices in North America, Europe, Asia, and Australia.
Apax Partners LLP is a British private equity firm, headquartered in London, England. The company also operates out of six other offices in New York, Hong Kong, Mumbai, Tel Aviv, Munich and Shanghai. As of December 2017, the firm, including its various predecessors, have raised approximately $51 billion (USD) since 1981. Apax Partners is one of the oldest and largest private equity firms operating on an international basis, ranked the fifteenth largest private equity firm globally.
Cinven is a global private equity firm founded in 1977, with offices in nine international locations in Guernsey, London, New York, Paris, Frankfurt, Milan, Luxembourg, Madrid, and Hong Kong that acquires Europe and United States based corporations, and emerging market firms that fit with their core businesses, and necessitate a minimum equity investment of €100 million or more. In 2015, it had €10.6 billion in assets under management.
Perrigo Company plc is an American Irish–registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, MI, within Michigan State University's Grand Rapids Innovation Park.
Permira is a global investment firm. Founded in 1985, the firm advises funds with assets under management of €60+ billion. The Permira funds have made approximately 300 private equity investments in four key sectors: Technology, Consumer, Services and Healthcare. Permira employs over 360 people in 16 offices across North America, Europe and Asia.
CVC Capital Partners is a Luxembourg-based private equity and investment advisory firm with approximately US$133 billion of assets under management and approximately €157 billion in secured commitments since inception across American, European and Asian private equity, secondaries and credit funds. As of 31 December 2021, the funds managed or advised by CVC are invested in more than 100 companies worldwide, employing over 450,000 people in numerous countries. CVC was founded in 1981 and, as of 31 March 2022, has over 650 employees working across its network of 25 offices throughout EMEA, Asia and the Americas.
Goldman Sachs Capital Partners is the private equity arm of Goldman Sachs, focused on leveraged buyout and growth capital investments globally. The group, which is based in New York City, was founded in 1986. As of 2019, GS Capital Partners had raised approximately $39.9 billion since inception across seven funds and has invested over $17 billion.
Fortress Investment Group is an American investment management firm based in New York City. Fortress was founded as a private equity firm in 1998 by Wes Edens, Rob Kauffman, and Randal Nardone. When Fortress launched on the NYSE in February 2007, it was the first large private equity firm in the US to be traded publicly. As of June 30, 2020, the firm manages approximately $45.5 billion alternative assets in private equity, liquid hedge funds and credit funds.
CITIC Securities Co., Ltd. is a Chinese full-service investment bank. It offers services in underwriting, research, brokerage, asset management, wealth management, and investment advisory. CITIC Securities was established in 1995 and it is headquartered in Shenzhen, Guangdong Province.
BC Partners is a British international investment firm with over $40 billion of assets under management across private equity, credit and real estate in Europe and North America. Its global headquarters are in London. The firm invests across all industries. BC Partners was founded in 1986 and has offices in New York, Paris, Milan and Hamburg. Since inception, BC Partners has completed 113 private equity investments in companies with a total enterprise value of €145 billion.
Hellman & Friedman LLC (H&F) is an American private equity firm, founded in 1984 by Warren Hellman and Tully Friedman, that makes investments primarily through leveraged buyouts as well as growth capital investments. H&F has focused its efforts on several core target industries including media, financial services, professional services and information services. The firm tends to avoid asset intensive or other industrial businesses. H&F is based in San Francisco, with offices in New York and London.
Marelli Corporation was a Japanese automotive company with 58 manufacturing centres spread throughout the United States, European Union, South Korea, Mexico, Thailand, South Africa, India, China, and Malaysia.
Avista Capital Partners is an American private equity firm headquartered in New York City focused on growth capital and leveraged buyout investments in middle-market companies in the domestic healthcare sector.
WH Group, formerly known as Shuanghui Group, is a publicly traded Chinese multinational meat and food processing company headquartered in Hong Kong. Sometimes also known as Shineway Group in English-speaking countries, the company's businesses include hog raising, consumer meat products, flavoring products, and logistics. It is the largest meat producer in China.
In the 1970s and 1980s, a large number of people – most of whom had haemophilia – were infected with hepatitis C and HIV, the virus that leads to acquired immune deficiency syndrome (AIDS), as a result of receiving contaminated clotting factor products. In the United Kingdom, these were supplied by the National Health Service (NHS). The Haemophilia Society estimates that around 4,700 people with bleeding disorders were infected, with some estimates as high as 6,000. As of August 2022, at least 2,400 people have died from the use of contaminated factor VIII and factor IX clotting agents and the viruses they transmitted.
The pharmaceutical industry in the United Kingdom directly employs around 73,000 people and in 2007 contributed £8.4 billion to the UK's GDP and invested a total of £3.9 billion in research and development. In 2007 exports of pharmaceutical products from the UK totalled £14.6 billion, creating a trade surplus in pharmaceutical products of £4.3 billion.
The Bio Products Laboratory (BPL) is a company involved in the manufacture of human blood plasma products, located in Elstree in the United Kingdom. BPL was a state owned organization and it was part of the U.K. National health Service for most of its existence. Today BPL is owned by the Creat Group, a Chinese investment firm. Before August 2016, it had been owned by Bain Capital (80%) and the UK Government (20%) via holding company Plasma Resources UK Ltd. BPL is run as a commercial business and supplies plasma derived products to the National Health Service in the UK as well as to markets in over 45 countries.
BHR Partners is a private investment fund founded in 2013 by Bohai Industrial Investment Fund Management Co., Ltd., which is controlled by Bank of China Limited along with a partnership with Hunter Biden, and whose focus is on mergers and acquisitions, and investment in, and reforms, of state-owned enterprise.
References
- ↑ "Introduction to Creat". Creat Group. Retrieved 29 May 2017.
- ↑ "Creat Group". CB Insights. Retrieved 12 November 2022.
- ↑ "Creat Group Corporation agrees to acquire Bio Products Laboratory Ltd". Bain Capital. 18 May 2016. Retrieved 14 April 2017.
- ↑ "Biotest agrees to takeover by China's Creat in 1.3 billion euro deal". Reuters. 2017-04-07. Retrieved 2019-02-14.
- ↑ "China's Creat makes 1.2 billion euro bid for German blood plasma firm". Reuters. 30 March 2017. Retrieved 29 May 2017.
- ↑ "Iain Duncan Smith calls for review of Chinese investment in UK". Guardian. 11 October 2020. Retrieved 12 November 2022.